Gene · 7317
Papers2,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical characteristics and a screening tool for VEXAS syndrome: a case-control study from China. | Orphanet J Rare Dis | 2026 | 42316235 | PubTator, text mining | PubMed |
| The E3 ligase MKRN2 prevents DRiP accumulation in stress granules and maintains granulostasis. | EMBO Rep | 2026 | 42297957 | PubTator, text mining | PubMed |
| GIPC2 suppresses colorectal cancer progression via regulation by UBA1-mediated ubiquitination. | Gastroenterol Rep (Oxf) | 2026 | 42294459 | PubTator, text mining | PubMed |
| A rapid, accessible real-time PCR approach to identify UBA1 somatic mutations in VEXAS syndrome. | Front Med (Lausanne) | 2026 | 42292277 | PubTator, text mining | PubMed |
| Myelodysplasia in VEXAS syndrome. | Blood Adv | 2026 | 42284697 | PubTator, text mining | PubMed |
| Tumor-enriched circRNA TAFCR1 drives cancer progression and metastasis by disrupting UBE1-dependent TRIM21-mediated CD44 ubiquitination. | Biomark Res | 2026 | 42265572 | PubTator, text mining | PubMed |
| Cell autonomous inflammation in VEXAS is mediated by cGAS-STING. | bioRxiv | 2026 | 42244578 | PubTator, text mining | PubMed |
| Allogeneic hematopoietic stem cell transplantation for VEXAS syndrome: A review and a case report. | Clin Hematol Int | 2026 | 42221689 | PubTator, text mining | PubMed |
| A neurologist's guide to VEXAS syndrome: Differentiating somatic autoinflammation from autoimmune mimics. | Intractable Rare Dis Res | 2026 | 42221042 | PubTator, text mining | PubMed |
| UBA1-CDK16: A female-specific chimeric RNA emerging through evolution and involved in immune regulation. | Sci Adv | 2026 | 42213831 | PubTator, text mining | PubMed |
| VEXAS Syndrome: Clinical Features, Hematologic Involvement, and Clinical Outcomes of Current and Emerging Therapies. | Hematol Rep | 2026 | 42200825 | PubTator, text mining | PubMed |
| Ophthalmic Artery Vasculitis in VEXAS Syndrome: A Novel, Vision-Threatening Manifestation. | Ocul Immunol Inflamm | 2026 | 42160723 | PubTator, text mining | PubMed |
| PARylation-centric crosstalk: orchestrating immune evasion and multidrug resistance in ovarian cancer. | Front Immunol | 2026 | 42148103 | PubTator, text mining | PubMed |
| VEXAS syndrome: a comprehensive clinicopathologic and genetic analysis of a predominantly Indian cohort. | J Hematop | 2026 | 42142282 | PubTator, text mining | PubMed |
| When Inflammation Mimics Malignancy: Recognizing VEXAS Syndrome in Oncology Practice. | Kans J Med | 2026 | 42137383 | PubTator, text mining | PubMed |
| Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD. | Front Immunol | 2026 | 42136657 | PubTator, text mining | PubMed |
| VEXAS Syndrome: First Genetically Confirmed Case Report from Tunisia. | Curr Rheumatol Rev | 2026 | 42136441 | PubTator, text mining | PubMed |
| Systemic inflammation with myelodysplastic features: VEXAS syndrome. | BMJ Case Rep | 2026 | 42128440 | PubTator, text mining | PubMed |
| Assessing the Frequency of VEXAS-Related Canonical UBA1 Mutations in Myelodysplastic Syndrome Patients. | Eur J Haematol | 2026 | 42107927 | PubTator, text mining | PubMed |
| The profile of clinical and laboratory features of Chinese VEXAS syndrome patients with hematological abnormalities: a single-center case series. | Front Immunol | 2026 | 42079602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7317/papers?page=3